• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,563.92 -1,470.50
( -1.93%)
Global Indices
Nasdaq
46,702.98 -735.30
(-1.55%)
Dow Jones
6,694.68 -102.12
(-1.50%)
Hang Seng
53,838.16 -614.80
(-1.13%)
Nikkei 225
10,249.42 -55.73
(-0.54%)
Forex
USD-INR
91.92 0.02
(0.02%)
EUR-INR
106.58 -0.28
(-0.27%)
GBP-INR
123.39 -0.12
(-0.10%)
JPY-INR
0.58 0.00
(-0.46%)

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500124
INE089A01031
377.5573934
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DRREDDY
23.72
110068.55
EPS(TTM)
Face Value()
Div & Yield %
55.59
1
0.61
 

saregama india ltd
Anant Raj gains after Q3 PAT jumps 31% YoY to Rs 144 crore
Jan 22,2026
Revenue from operations jumped 20% YoY to Rs 641.59 crore for the quarter ended 31 December 2025.

Profit before tax stood at Rs 171.78 crore in Q3 FY26, marking a growth of 30.38% from Rs 131.75 crore reported in Q3 FY25.

Total expenses rose 18.52% to Rs 488.60 crore in Q3 FY26, compared with Rs 412.22 crore in Q3 FY25. Cost of sales stood at Rs 443.63 crore (up 17.28% YoY), employee benefit expenses were Rs 9.92 crore (up 88.23% YoY), while finance costs increased 13.35% YoY to Rs 3.31 crore during the period under review.

On a nine-month basis, Anant Raj’s consolidated net profit jumped 33.02% YoY to Rs 408.25 crore, while revenue increased 22.73% YoY to Rs 1,864.79 crore in 9M FY26 compared with the same period last year.

Anant Raj is a diversified real estate company focused on developing IT parks, hospitality projects, data centers, office complexes, shopping malls, and residential projects in India. The company has a strong presence in Delhi, Haryana, Andhra Pradesh, Rajasthan, and other parts of the NCR region.